Loading...
Projects / Programmes source: ARIS

Hospital consumption of antimicrobial agents in Slovenia 2007-2009

Research activity

Code Science Field Subfield
3.01.00  Medical sciences  Microbiology and immunology   

Code Science Field
B510  Biomedical sciences  Infections 
Keywords
Antimicrobial agents, data colection, hospitals, drug utilization, Slovenia, factual databases, microbial drug resistance
Evaluation (rules)
source: COBISS
Researchers (8)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  08312  PhD Bojana Beovič  Microbiology and immunology  Researcher  2007 - 2009  467 
2.  10981  PhD Milan Čižman  Microbiology and immunology  Head  2007 - 2009  452 
3.  11330  PhD Tatjana Lejko-Zupanc  Microbiology and immunology  Researcher  2007 - 2009  370 
4.  23436  PhD Tina Plankar Srovin  Public health (occupational safety)  Junior researcher  2007 - 2009  45 
5.  15476  PhD Marko Pokorn  Microbiology and immunology  Researcher  2007 - 2009  307 
6.  24090  Jona Rakuš  Microbiology and immunology  Researcher  2007 - 2009 
7.  20474  Simona Rojs    Technical associate  2007 - 2009 
8.  19775  MSc Breda Zakotnik Vihar  Microbiology and immunology  Researcher  2007 - 2009  115 
Organisations (1)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  77,921 
Abstract
The aim of the proposed project is to collect data on hospital consumption of antimicrobial drugs (including antibacterial, antiviral and antifungal) in all 29 Slovenian hospitals. Antimicrobial consumption will be collected from all hospital departments and expressed in defined daily doses (DDD) per 100 bed-days, in DDD per 100 hospital admissions and in DDD per 1000 inhabitants per day according to the Anatomic Therapeutic Classification (ATC) by the WHO. Indicators of quality antibiotic prescribing will be determined, using total antibiotic consumption, antibiotic class consumption, the ratio of oral-to-parenteral consumption and the antibiotic consumption-per patient-diagnosis. The data on antibiotic consumption will be regularly sent to participating hospitals, in case of above average consumption a visit will be paid to the hospital, physician education will be organized and other actions to reduce antibiotic consumption will be undertaken.
Significance for science
In the literature we did not found the data on the consumption of antimicrobials in hospital care at nationwide, type of hospital and department level. Slovenia is participating country in EU project - European Surveillance on antibiotic consumption (ESAC). The results of the ESAC project are published in peer reviewed journals including the results of Slovenia. At the moment we collect the data on the use of antiviral drugs in ambulatory and hospital care.
Significance for the country
The data of this project are very important for Slovenia. They provide the base for improvement of antibiotic use in hospitals. The data are regularly used in education of hospital physicians. Beside these data are used to study the relathionship between antibiotic use and development of antibiotic resistance. It is recommended by European Council to monitor such data and they will be submited to ECDC after the year to 2010. We updated the collection and reporting the data to every hospital. We evaluated also the costs of antimicrobials at hospital level. Medical directors are very interested in these data. Our monitoring system of antimicrobial use is the model for colecting the consumption of other drugs used in hospitals.
Most important scientific results Annual report 2008, final report, complete report on dLib.si
Most important socioeconomically and culturally relevant results Annual report 2008, final report, complete report on dLib.si
Views history
Favourite